外周血同型半胱氨酸水平升高与精神分裂症相关:病例对照研究与荟萃分析
该研究通过病例对照研究(1159例精神分裂症患者和1440例健康对照)和荟萃分析(54项病例对照研究,9781名参与者)发现,精神分裂症患者血同型半胱氨酸水平显著高于健康对照,且在校正年龄和性别后关联仍显著。荟萃分析显示患者同型半胱氨酸水平较对照高34%(RoM 1.34,95%CI 1.28-1.41,P<0.001),亚组分析结果一致。
要点
- 精神分裂症患者血同型半胱氨酸水平显著高于健康对照。
- 荟萃分析纳入54项研究,患者同型半胱氨酸水平较对照高34%。
- 关联在调整年龄和性别后仍显著,亚组分析结果一致。
核心结论
- 病例对照研究和荟萃分析均显示精神分裂症患者血同型半胱氨酸水平升高,提示同型半胱氨酸与精神分裂症可能存在关联。
研究设计与样本
- 病例对照研究纳入1159例DSM-5诊断的精神分裂症患者和1440例健康对照,比较血浆同型半胱氨酸水平。
- 荟萃分析系统检索PubMed、Embase、Cochrane Library和Web of Science截至2024年2月,纳入54项病例对照研究(4526例患者和5255例对照)。
主要发现
- 病例对照研究中,患者同型半胱氨酸水平为14.4 [11.3-21.6] µmol/L,显著高于对照的12.3 [10.1-15.7] µmol/L(P < 0.001)。
- 校正年龄和性别后,患者与对照的同型半胱氨酸水平差异仍显著。
- 荟萃分析显示患者同型半胱氨酸水平显著高于对照(RoM 1.34,95% CI 1.28-1.41;P < 0.001)。
- 按病程、样本类型、性别、研究地区和同型半胱氨酸测量方法进行亚组分析,结果一致。
临床怎么用
- 精神分裂症患者可考虑监测血同型半胱氨酸水平,但尚不能作为诊断或治疗依据。
局限性
- 需要进一步设计良好的前瞻性和纵向研究来阐明同型半胱氨酸的临床意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Several studies suggest that homocysteine is associated with schizophrenia (SCZ), but existing evidence has been limited by small sample sizes. We aimed to investigate the association between blood homocysteine levels and schizophrenia. We conducted a case-control study followed by a meta-analysis. In the case-control study, 1159 patients with SCZ diagnosed according to DSM-5 (mean age 22.6 ± 8.4 years; 51.9% male) and 1440 healthy controls (HC) (mean age 38.4 ± 9.7 years; 51.3% male) were recruited. Plasma homocysteine levels were measured using an AU5800 automated biochemical analyzer and compared between groups. For the meta-analysis, PubMed, Embase, Cochrane Library, and Web of Science were systematically searched through February 2024 for case-control studies comparing blood homocysteine levels between patients with SCZ and HC. Ratios of means (RoM) with 95% confidence intervals were pooled using random effects models. In the case-control study, patients with SCZ had significantly higher homocysteine levels than HC (14.4 [11.3-21.6] vs. 12.3 [10.1-15.7] µmol/L; P < 0.001), and the association remained significant after adjustment for age and sex. Consistently, the meta-analysis of 54 case-control studies including 9781 participants (4526 patients with SCZ and 5255 HC) showed significantly higher homocysteine levels in patients with SCZ than in HC (RoM 1.34, 95% CI 1.28-1.41; P < 0.001). Subgroup analyses stratified by disease course, sample type, sex, study region, and homocysteine measurement method yielded consistent results. Blood homocysteine levels are elevated in patients with SCZ in both the case-control analysis and meta-analysis. These preliminary findings suggest a possible association between homocysteine and SCZ, although further well-controlled prospective and longitudinal studies are needed to clarify its clinical significance.
引用
- Bi Y, Zhu L, Li L, et al. Higher peripheral blood homocysteine levels are associated with schizophrenia: evidence from a case-control study and a meta-analysis. Mol Psychiatry. 2026. PMID: 42773153. doi:10.1038/s41380-026-03910-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。